Literature DB >> 10513914

Factors predictive of quality of life after silicone-implant explanation.

R J Rohrich1, R Rathakrishnan, J B Robinson, J R Griffin.   

Abstract

'Medical records of 180 patients who underwent silicone gel-filled breast implant explanation were retrospectively reviewed. The goal of this study was to determine if any patient variable(s) had predictive value for positive quality of life after explanation. The medical complaints, symptoms, and established diagnoses were considered equally and were referred to as self-reported medical problems. The study revealed that no single problem or pairing of problems was associated with or predictive of outcome. The results show, however, that the number of medical problems was significantly predictive of patient perception of quality of life. A total of 50 explanation patients completed quality-of-life surveys. Specifically, those patients who reported five or fewer medical problems that predated explantation were significantly more likely to perceive an increased quality of life after surgery than those who reported nine or more medical problems (p < 0.04). In conclusion, it is difficult to correlate subjective patient symptoms with postoperative improvements in quality of life after explantation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10513914     DOI: 10.1097/00006534-199910000-00014

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  2 in total

1.  Halo and spillover effect illustrations for selected beneficial medical devices and drugs.

Authors:  Brent D Kerger; Autumn Bernal; Dennis J Paustenbach; Gavin Huntley-Fenner
Journal:  BMC Public Health       Date:  2016-09-15       Impact factor: 3.295

2.  The Prevalence of Self-Reported Health Complaints and Health-Related Quality of Life in Women With Breast Implants.

Authors:  Renée M L Miseré; Maartje J L Colaris; Jan W Cohen Tervaert; René R W J van der Hulst
Journal:  Aesthet Surg J       Date:  2021-05-18       Impact factor: 4.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.